Excel Venture Management

Excel Venture Management builds companies that apply transformative life science technologies to solve problems in healthcare and beyond. The Excel investment portfolio is balanced across healthcare IT and services, diagnostics, and medical devices, plus life science platforms that address adjacent markets including energy, chemicals, defense and agriculture. The majority of the team’s prior investments, which include some of the world’s premier healthcare and life science companies, are thriving and over half have achieved successful exits generating billions in value. Excel Venture Management is a spin-off of CB Health Ventures.

Rick Blume

MD

Gaye Bok

Venture Partner

Juan Enriquez

MD

Steve Gullans

MD

Jeanne Henry

CFO

DJ

Daniel J. Mitchell

Former Member of Business Advisory Board

Tricia Moriarty

VP of Finance and Administration

CS

Chris Seitz

Venture Fellow

Caleb Winder

MD

65 past transactions

Skylight

Series C in 2008
Currently serving the San Francisco Bay Area as a licensed General Contractor, Skylight delivers full service renovations for kitchens, bathrooms and other interior spaces. The Skylight process is fully digital and fully integrated – from planning the space based on lifestyle, to personalized curation of materials, right through to permitting, construction and the final close-out package. Skylight was created to fix the problems with the traditional renovation experience.

WellDoc

Series B in 2015
WellDoc is developing the next generation of technology solutions to support chronic disease management. Its mission is to improve the lives of people with chronic diseases they fulfill their mission by integrating clinical, behavioral, and motivational applications with everyday technologies, like the internet and cell phone, to engage patients and healthcare providers in ways that dramatically improve outcomes and significantly reduce healthcare costs. It was founded in 2005 and headquartered in Columbia, Maryland.

MedVentive

Series D in 2011
MedVentive provides leading-edge technology solutions that enable physician groups, integrated delivery systems, health plans and self-insured employers to effect meaningful and measurable change in the quality and cost of the care they deliver to patients. Founded in 1997 by physicians, MedVentive has been at the forefront of the development of innovative and clinically sophisticated solutions to reduce healthcare costs and improve healthcare quality.

TransMedics Group, Inc.

Series E in 2010
TransMedics, Inc. operates as a medical technology company. It offers organ care system, a multi-organ preservation technology that mirrors human physiology, minimizes ischemia, and provides the ability to optimize the organ during transport. The company is headquartered in Andover, Massachusetts.

Openwater

Seed Round in 2018
Openwater designs and develops MRI-resolution wearables that medical diagnoses and treatments, and a new era of fluid and affordable brain-to-computer communications to consumer electronics manufacturing facilities and techniques. The company was founded in 2016 and is based in San Francisco, California.

InfoBionic, Inc.

Venture Round in 2018
InfoBionic transforms the efficiency and the economics of ambulatory remote patient monitoring processes and cardiac diagnostic services by optimizing clinical and real-world utility for the users that need it most – physicians and their patients. It has developed the MoMe System, a remote patient monitoring platform initially focused on cardiac arrhythmia detection, to improve clinical efficiency and patient care with any time, anywhere access to patient data. The company was founded in 2011 and is headquartered in Waltham, Massachusetts.

RxGen

Venture Round in 2008
RxGen, Inc. is a biotechnology company that develops therapeutics for central nervous system disorders such as neurodegeneration, memory loss, and obesity. The company utilizes PrimaTox, which is a predictive toxicogenomics platform that enables pharmaceutical candidate selection and pre-clinical validation. RxGen is based in Hamden, Connecticut.

Xcellerex

Venture Round in 2009
Xcellerex is a supplier of manufacturing technologies, developing and producing biomanufacturing systems and production-scale bioreactors. The biomanufacturing solutions transform the speed and economics of producing therapeutic proteins, including biosimilars and vaccines. Its proprietary products offer significant advantages such as faster installation, lower capital investment, reduced risk of cross-contamination, and significantly increased flexibility compared with traditional manufacturing technologies. The company’s FlexFactory® is a completely modular and portable production train based on single-use technologies, advanced process automation, and compact cleanroom architecture. In 2002, the company was founded by Parrish M. Galliher inMarlborough, Massachusetts.

BioTrove

Series C in 2009
BioTrove, Inc. provides micro and nano-scale technology platforms for life science and drug discovery research applications. The company offers OpenArray, a technology platform for relative gene expression analysis that advances genomic research in various life science fields, including agriculture, disease research, and public health; RapidFire, a technology platform that enables the screening of intractable drug targets via mass spectrometry based assay development; and RapidFire mass spectrometry hardware system, a native detection technology for drug screening and in vitro ADME applications.

Openwater

Seed Round in 2018
Openwater designs and develops MRI-resolution wearables that medical diagnoses and treatments, and a new era of fluid and affordable brain-to-computer communications to consumer electronics manufacturing facilities and techniques. The company was founded in 2016 and is based in San Francisco, California.

Zipongo

Series B in 2016
Are you an employer or health plan looking for an easy way to engage individuals in healthy and sustainable eating habits that drive positive results for you and your employees or members? You’ve come to the right place. Foodsmart’s program delivers uniquely personalized food recommendations tied to content and tools that enable healthy eating at home and at work. Our scalable, easy-to-implement platform offers health plans and employers actionable data and insights into how diet affects the overall health of their employees. The result: positive member and employee health outcomes, and significant reductions in health costs. Learn more at www.foodsmart.com

Gemphire Therapeutics

Seed Round in 2015
Gemphire Therapeutics manufactures and markets Gemcabene, an LDL cholesterol-lowering medication. It is a clinical-stage biopharmaceutical company that is committed to helping patients with cardiometabolic disorders, including dyslipidemia and NASH. The company was founded in 2014 and is based in Northville, Michigan.

Synthetic Genomics

Venture Round in 2010
Synthetic Genomics, Inc. operates as a biotechnology company that develops transformative medicines and bio-based products. The company, through its RNA replicon platform, stimulates the immune system and delivers targeted therapies produced within a person’s own body. Its portfolio includes algal-based biodiesel; and Cmax, a microbial host to transform biologics drug production. The company also focuses on developing biologics, including monoclonal antibodies, single domain antibodies, biospecifics, and therapeutic enzymes. It serves pharmaceutical companies, biotech companies, and contract manufacturing organizations. Synthetic Genomics, Inc. was formerly known as Synthetic Genomic Solutions, Inc. The company was founded in 2005 and is based in La Jolla, California.

IPC-The Hospitalist Company

Venture Round in 2008
IPC is the nation's leading national physician group practice focused on the delivery of hospital medicine and related facility-based services. IPC providers manage the care of patients in coordination with primary care physicians and specialists in over 1,100 facilities in 28 states across the U.S. We provide care to over 1 million patients annually while maintaining high standards of quality care, aligning with the mission and objectives of the facilities where we serve.

Molecular Templates, Inc.

Venture Round in 2014
Molecular Templates Inc. (MTI) is a biopharmaceutical company with a novel protein platform for the development of new therapeutics against cancer. The company has a lead compound for melanoma that is expected to enter into clinical trials in the next two years and is developing additional compounds against a variety of other cancers.

ShapeUp

Series B in 2013
ShapeUp is the leading provider of clinically-proven social networking-powered corporate wellness solutions. ShapeUp covers more than 2 million lives on its online platform and serves more than 500 employers and health plans in 109 countries. It was founded in 2006 and headquartered in Providence, Rhode Island.

Exact Sciences

Post in 2009
Exact Sciences is a molecular diagnostics company focused on colorectal cancer. The company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. Stool-based DNA (sDNA) technology is included in the colorectal cancer screening guidelines of the American Cancer Society and the U.S. Multi-Society Task Force on Colorectal Cancer.

Ayogo Health

Series A in 2015
Ayogo Health Inc. develops games and applications for management of chronic health conditions and patient adherence. Its products include GoodLife, a customizable platform that uses tailor-made gamification components, incentives, and social features; and Alternate Reality Games, a suite of learning applications which combines online and real-world elements. The company was founded in 2008 and is based in Vancouver, Canada.

N-of-One, Inc.

Series B in 2016
N-of-One Therapeutics provides cancer care services. Its team of clinicians and scientists works with a network of diagnostic laboratories, research institutions, and cancer experts to provide access to cancer research, medical science, and molecular diagnostic testing. The company conducts research to assess the standard of care and other diagnostic and treatment opportunities for various cancer types.

BIOCIUS Life Sciences

Seed Round in 2010
BIOCIUS Life Sciences, Inc. engages in the drug discovery research. The company was incorporated in 2009 and is based in Woburn, Massachusetts. BIOCIUS Life Sciences, Inc. operates as a subsidiary of BioTrove, Inc.

Ayogo Health

Series B in 2020
Ayogo Health Inc. develops games and applications for management of chronic health conditions and patient adherence. Its products include GoodLife, a customizable platform that uses tailor-made gamification components, incentives, and social features; and Alternate Reality Games, a suite of learning applications which combines online and real-world elements. The company was founded in 2008 and is based in Vancouver, Canada.
Aileron Therapeutics is a biopharmaceutical company that develops a class of drugs called Stapled Peptides. Stapled Peptides represent the first general solution for modulating intracellular protein-protein interactions that are critical control points to nearly all functions of a cell. It was founded in 2005 and headquartered in Cambridge, Massachusetts.

Passport Health Communications

Venture Round in 2008
Passport Health Communications, Inc., a software-as-a-service company, provides revenue cycle management solutions and platforms. The company offers eCare Patient Access Suite, including solutions for patient demographic and insurance verification, compliance, and managing patient payments; OrderChecker that validates outpatient diagnosis and procedure codes; and IntelliSource, an integrated patient access system. It also provides OneSource, a Web-based user interface, which enables to verify patient demographic and insurance information, identify coverages, maintain payer compliance, and estimate and collect patient payments; BatchSource that allows for automation to upload, process, and download files for various transactions across the revenue cycle; and Registration Quality Assurance, a Web-based integrated solution, which automatically launches insurance eligibility real-time. In addition, the company offers Patient Payment Estimator that calculates estimates based on price information; eCashiering, a solution for processing patient payments prior to or at the point of service; Claims Management Suite, which provides solutions and services for claims submission, editing, denials, and reimbursements; Payment Navigator, an automated financial screening tool; and OrderRite, a single-user interface to submit, validate, and manage pre-certifications. Further, it provides patient verification, compliance, and payment management services. The company serves health care organizations, including hospitals, physician offices, surgery centers, durable medical equipment facilities, and skilled nursing facilities. Passport Health Communications was formerly known as InterMed, LLC and changed its name to Passport Health Communications, Inc. in 1998. The company was founded in 1996 and is headquartered in Franklin, Tennessee. Passport Health Communications, Inc. operates as a subsidiary of Passport Holding, Corp.

IntraPace, Inc.

Venture Round in 2010
IntraPace® has developed a novel implantable system to treat obesity. It is built on the proven technology used in millions of cardiac pacemakers and defibrillators each year. The abiliti® system is designed to be implanted via standard laparoscopic instruments without making any changes to the anatomy of the digestive system or placing any limitations on what a person can eat or drink.

Zipongo

Series A in 2014
Are you an employer or health plan looking for an easy way to engage individuals in healthy and sustainable eating habits that drive positive results for you and your employees or members? You’ve come to the right place. Foodsmart’s program delivers uniquely personalized food recommendations tied to content and tools that enable healthy eating at home and at work. Our scalable, easy-to-implement platform offers health plans and employers actionable data and insights into how diet affects the overall health of their employees. The result: positive member and employee health outcomes, and significant reductions in health costs. Learn more at www.foodsmart.com

Virgin Pulse

Venture Round in 2010
Virgin Pulse, part of Sir Richard Branson’s Virgin Group, designs technology that cultivates good lifestyle habits for your employees. Configured to complement your culture, our technology, and the overall well-being experience we deliver, drives superior outcomes for your people and your business. Virgin – one of the world’s most recognized and respected brands – is known for creating unrivaled consumer experiences. Conceived in 1970 by Branson, the brand believes in insatiable curiosity, smart disruption, heartfelt service, and delightful experiences.

Activate Networks

Series B in 2012
Activate Networks, Inc. is a network analytics company that identifies and understands the key social connections that drive commercial, organizational, and health results. Activate Networks' suite of analytics products and software enables organizations to unlock the commercial value of their customer, prospect, voter, and employee real-world social networks commonly using data already available in the organization. Activate Networks maps, analyzes, and activates networks across a range of industry verticals, from healthcare to technology, to political campaigns and professional services. Our powerful proprietary RealConnect™ social network analytics platform creates unique, actionable insights that have a direct, measurable impact on marketing campaigns, health-behavior change programs, talent management, innovation, and more.

Forhealth Technologies

Venture Round in 2008
Forhealth Technologies is focused on the development of automation technology solutions for the process of intravenous drug preparation. Forhealth Technologies was acquired by Baxa Corporation in March 2009. Forhealth Technologies was founded in 1998 and is based in Daytona Beach, Florida.

Zonare Medical Systems

Venture Round in 2008
ZONARE Medical Systems, Inc. develops, manufactures, and commercializes compact ultrasound systems that are used for diagnostic imaging in a range of clinical applications and settings. Its product platform, the z.one ultrasound system, is based on its unique data acquisition and image formation technology, Zone Sonography. Zone Sonography technology enables customers to maintain an ultrasound system, and add new clinical applications and advanced image processing capabilities. ZONARE Medical sells its systems through direct sales force in the United States, and through a combination of distributors and direct sales personnel in approximately 40 international markets. The company, formerly known as NovaSonics, Inc., was founded in 1999 and is headquartered in Mountain View, California.

Carefx

Venture Round in 2009
Carefx's main solution "Fusionfx" helps close information gaps between hospital/IDN CIO and CMIO and healthcare IT departments. Fusionfx is able to help "synthesize disparate data into clinically relevant, user-centric workflows." The solution aims to connect the data points and make it comprehensive/understandable fo patients, payers, clinicians, and the compliance agencies who seek such information.

Emageon

Post in 2008
Emageon provides an enterprise-level information technology solution for the clinical analysis and management of digital medical images within health care provider organizations.

Cleveland HeartLab

Series B in 2012
Cleveland HeartLab, Inc. is a specialty clinical laboratory and disease management company focused on novel biomarker technologies and the creation of proprietary diagnostic tests.

Orionis Biosciences

Seed Round in 2015
Orionis Biosciences operates in the healthcare industry focusing on the biotechnology business and innovation. The company is an early-stage drug discovery and development biotechnology company fueled by a suite of disruptive technologies to advance innovative medicines for the treatment of diseases with high unmet medical needs – with an initial internal focus in oncology and immunotherapies. Orionis Biosciences has research facilities in the Boston area (Headquarters in Waltham, MA, USA) and Ghent (Belgium), and is operated by a world class team of entrepreneurs, scientists and transatlantic network of investors, in concert with strategic research and development collaborations. The latter includes collaborations with VIB (Belgium), Orionis Biosciences co-founding institution.

Oculus Health, Inc.

Series A in 2017
Oculus Health provides the support, insights, and passion needed for primary care and specialty providers to be successful in a changing health care environment. They improve patient outcomes and bring joy back to the practice of medicine, all while growing your revenues.

Lantos Technologies, Inc.

Venture Round in 2011
Lantos Technologies is the only FDA-cleared 3D ear scanning system that enables custom, in-ear products with superior comfort, sound quality, and performance. Our technology enables the efficient and effective delivery of customized hearing aids and other hearing-related products.

CareMedic Systems

Venture Round in 2008
CareMedic Systems, Inc. provides revenue cycle management solutions to hospitals and healthcare providers in the United States and Puerto Rico. It offers electronic Financial Record, a healthcare financial management system that provides activity tracking capabilities, and recording descriptions and dates for various events that occur inside or outside the patient accounting system; and VerifyAR, a solution for front-end document management, eligibility verification, compliance checking, and medical necessity review. The company also provides AccelerateAR, a Medicare review and editing solution with document management, all-payer claims formatting and submission, and print and mail service capabilities; and OptimizeAR, a solution that offers tools for managing payments through remittance management, denial management, and paper EOB to electronic 835 conversions. In addition, it offers ImageAR, a document management system with integrated front and back-end scanning, indexing, and storage solutions that enable and streamline various revenue cycle functions; and ResolveAR, a suite of service offerings, including accounts receivables outsourcing, Medicare accounts receivables cleanup, and credit balance resolution. The company provides its solutions in application service provider (ASP) model. CareMedic Systems, Inc. was founded in 1996 and is based in St. Petersburg, Florida with additional offices in Alpharetta and Decatur, Georgia.
Aileron Therapeutics is a biopharmaceutical company that develops a class of drugs called Stapled Peptides. Stapled Peptides represent the first general solution for modulating intracellular protein-protein interactions that are critical control points to nearly all functions of a cell. It was founded in 2005 and headquartered in Cambridge, Massachusetts.

Springleaf Therapeutics

Series B in 2011
SpringLeaf Therapeutics (formerly known as Entra Pharmaceuticals, Inc.) is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf's technology is based on convergent science and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including Flybridge Capital Partners and North Bridge Venture Partners.

Aventura Software

Series C in 2015
Aventura intelligently orchestrates assets, people, and systems to deliver the right information at the right time based on location and credentials. It locates and re-assigns the closest online printer and uniquely manages print routing to make it easier to detect and fix printing failures. Aventura was formed in 2007 and headquartered in Denver, Colorado.

Catch.com

Seed Round in 2010
Catch.com (formerly Snaptic) is a market leader for Android smartphones and tablets. Millions have downloaded our mobile apps, including Catch Notes, AK Notepad and Compass. Our mobile apps also run on iOS and the web, and we are just getting started. Catch.com was founded in 2008 and is on the cusp of a seismic shift driven by growth in smartphone use -- reinventing how people interact, collaborate and discover what’s important to them.

Lantos Technologies, Inc.

Venture Round in 2010
Lantos Technologies is the only FDA-cleared 3D ear scanning system that enables custom, in-ear products with superior comfort, sound quality, and performance. Our technology enables the efficient and effective delivery of customized hearing aids and other hearing-related products.
Aileron Therapeutics is a biopharmaceutical company that develops a class of drugs called Stapled Peptides. Stapled Peptides represent the first general solution for modulating intracellular protein-protein interactions that are critical control points to nearly all functions of a cell. It was founded in 2005 and headquartered in Cambridge, Massachusetts.

Catch.com

Series A in 2011
Catch.com (formerly Snaptic) is a market leader for Android smartphones and tablets. Millions have downloaded our mobile apps, including Catch Notes, AK Notepad and Compass. Our mobile apps also run on iOS and the web, and we are just getting started. Catch.com was founded in 2008 and is on the cusp of a seismic shift driven by growth in smartphone use -- reinventing how people interact, collaborate and discover what’s important to them.

Pathogenetix

Series B in 2011
PathoGenetiX is developing an automated system for the rapid identification of pathogenic bacterial strains using proprietary Genome Sequence Scanning Technology. The company's approach, which employs a single reagent set to generate genomic bar codes based on bacterial DNA, can cost-effectively identify thousands of strains in a single test from complex samples in three hours. PathoGenetiX is developing its GSS platform for use in genomics research, food and product safety testing, and clinical infectious disease diagnostics, with the initial commercial introduction into the research market planned for 2012.

Aventura Software

Series A in 2011
Aventura intelligently orchestrates assets, people, and systems to deliver the right information at the right time based on location and credentials. It locates and re-assigns the closest online printer and uniquely manages print routing to make it easier to detect and fix printing failures. Aventura was formed in 2007 and headquartered in Denver, Colorado.
Aileron Therapeutics is a biopharmaceutical company that develops a class of drugs called Stapled Peptides. Stapled Peptides represent the first general solution for modulating intracellular protein-protein interactions that are critical control points to nearly all functions of a cell. It was founded in 2005 and headquartered in Cambridge, Massachusetts.

ShapeUp

Series A in 2010
ShapeUp is the leading provider of clinically-proven social networking-powered corporate wellness solutions. ShapeUp covers more than 2 million lives on its online platform and serves more than 500 employers and health plans in 109 countries. It was founded in 2006 and headquartered in Providence, Rhode Island.

NeoSensory, Inc.

Series A in 2019
NeoSensory, Inc. develops sensory augmentation wearable products for individuals. It offers Buzz, a vision-to-touch sensory substitution with the versatile extra sensory transducer for blind individuals. The company sells it products online and also offers a companion application for its product. The company was incorporated in 2015 and is headquartered in San Mateo, California.

ClearDATA

Series C in 2015
ClearDATA is the trusted managed cloud provider, designed for today’s healthcare security needs. More than 350,000 healthcare professionals trust the ClearDATA HIPAA-compliant cloud to safeguard their patient data and power their critical applications. ClearDATA protects sensitive healthcare data using compliance and security safeguards, purpose-built DevOps automation, and healthcare expertise — all backed by managed cloud services. This ensures healthcare organizations, and the technology providers that support them, are adhering to the highest standards in privacy, security and compliance in the cloud.

InfoBionic, Inc.

Series B in 2016
InfoBionic transforms the efficiency and the economics of ambulatory remote patient monitoring processes and cardiac diagnostic services by optimizing clinical and real-world utility for the users that need it most – physicians and their patients. It has developed the MoMe System, a remote patient monitoring platform initially focused on cardiac arrhythmia detection, to improve clinical efficiency and patient care with any time, anywhere access to patient data. The company was founded in 2011 and is headquartered in Waltham, Massachusetts.

Pathogenetix

Series B in 2011
PathoGenetiX is developing an automated system for the rapid identification of pathogenic bacterial strains using proprietary Genome Sequence Scanning Technology. The company's approach, which employs a single reagent set to generate genomic bar codes based on bacterial DNA, can cost-effectively identify thousands of strains in a single test from complex samples in three hours. PathoGenetiX is developing its GSS platform for use in genomics research, food and product safety testing, and clinical infectious disease diagnostics, with the initial commercial introduction into the research market planned for 2012.

MedVentive

Series C in 2009
MedVentive provides leading-edge technology solutions that enable physician groups, integrated delivery systems, health plans and self-insured employers to effect meaningful and measurable change in the quality and cost of the care they deliver to patients. Founded in 1997 by physicians, MedVentive has been at the forefront of the development of innovative and clinically sophisticated solutions to reduce healthcare costs and improve healthcare quality.

Aventura Software

Series B in 2013
Aventura intelligently orchestrates assets, people, and systems to deliver the right information at the right time based on location and credentials. It locates and re-assigns the closest online printer and uniquely manages print routing to make it easier to detect and fix printing failures. Aventura was formed in 2007 and headquartered in Denver, Colorado.

ClearDATA

Series D in 2017
ClearDATA is the trusted managed cloud provider, designed for today’s healthcare security needs. More than 350,000 healthcare professionals trust the ClearDATA HIPAA-compliant cloud to safeguard their patient data and power their critical applications. ClearDATA protects sensitive healthcare data using compliance and security safeguards, purpose-built DevOps automation, and healthcare expertise — all backed by managed cloud services. This ensures healthcare organizations, and the technology providers that support them, are adhering to the highest standards in privacy, security and compliance in the cloud.

Qstream

Series A in 2015
Qstream, Inc. develops a software as a service based mobile sales acceleration software for managing and measuring the human side of sales acceleration. It serves companies in technology, financial services, and life sciences sectors. Qstream, Inc. was formerly known as Spaced Education, Inc. The company was incorporated in 2008 and is based in Burlington, Massachusetts with engineering facilities in Dublin, Ireland; and Hood River, Oregon. It has a sales headquarters in Maidenhead, United Kingdom and an office in San Francisco.

IlluminOss Medical

Series C in 2012
IlluminOss Medical, Inc. is a commercial-stage medical device company offering a unique, minimally invasive technology for fracture repair and stabilization. The Company utilizes a light-curable polymer contained within an expandable balloon to create a patient-conforming intramedullary implant for bone stabilization. The revolutionary, minimally invasive technology is particularly applicable for repair and treatment of patients with osteoporotic and compromised bone. The IlluminOss system is CE-marked and FDA-cleared for a variety of anatomical sites, with further indications pending.

nanoMR

Series B in 2011
nanoMR has developed the first system for rapid isolation of rare cells from complex matrices at levels of 1 cell/mL or lower. The immunomagnetic capture system can target multiple cell types simultaneously, for example capturing bacteria and fungi from bloodstream infections, or specific cell types, such as circulating tumor, or fetal, cells, in less than 30 minutes.

Molecular Templates, Inc.

Series C in 2013
Molecular Templates Inc. (MTI) is a biopharmaceutical company with a novel protein platform for the development of new therapeutics against cancer. The company has a lead compound for melanoma that is expected to enter into clinical trials in the next two years and is developing additional compounds against a variety of other cancers.

Pathogenetix

Series C in 2013
PathoGenetiX is developing an automated system for the rapid identification of pathogenic bacterial strains using proprietary Genome Sequence Scanning Technology. The company's approach, which employs a single reagent set to generate genomic bar codes based on bacterial DNA, can cost-effectively identify thousands of strains in a single test from complex samples in three hours. PathoGenetiX is developing its GSS platform for use in genomics research, food and product safety testing, and clinical infectious disease diagnostics, with the initial commercial introduction into the research market planned for 2012.

ClearDATA

Series B in 2013
ClearDATA is the trusted managed cloud provider, designed for today’s healthcare security needs. More than 350,000 healthcare professionals trust the ClearDATA HIPAA-compliant cloud to safeguard their patient data and power their critical applications. ClearDATA protects sensitive healthcare data using compliance and security safeguards, purpose-built DevOps automation, and healthcare expertise — all backed by managed cloud services. This ensures healthcare organizations, and the technology providers that support them, are adhering to the highest standards in privacy, security and compliance in the cloud.

Cleveland HeartLab

Series B in 2011
Cleveland HeartLab, Inc. is a specialty clinical laboratory and disease management company focused on novel biomarker technologies and the creation of proprietary diagnostic tests.

ClearDATA

Series E in 2018
ClearDATA is the trusted managed cloud provider, designed for today’s healthcare security needs. More than 350,000 healthcare professionals trust the ClearDATA HIPAA-compliant cloud to safeguard their patient data and power their critical applications. ClearDATA protects sensitive healthcare data using compliance and security safeguards, purpose-built DevOps automation, and healthcare expertise — all backed by managed cloud services. This ensures healthcare organizations, and the technology providers that support them, are adhering to the highest standards in privacy, security and compliance in the cloud.

Saladax Biomedical, Inc.

Series C in 2010
Saladax develops rapid blood tests for point-of-care and for laboratory analyzers for use in psychiatry and oncology. The firm has been supplying laboratories and clinicians worldwide with revolutionary diagnostic solutions for more than 15 years.

Qstream

Series B in 2016
Qstream, Inc. develops a software as a service based mobile sales acceleration software for managing and measuring the human side of sales acceleration. It serves companies in technology, financial services, and life sciences sectors. Qstream, Inc. was formerly known as Spaced Education, Inc. The company was incorporated in 2008 and is based in Burlington, Massachusetts with engineering facilities in Dublin, Ireland; and Hood River, Oregon. It has a sales headquarters in Maidenhead, United Kingdom and an office in San Francisco.
Capitalizing on breakthrough synthetic chemistry, Tetraphase Pharmaceuticals is leveraging a dynamic drug engine targeted at several significant disease categories.